Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats
Authors:
- Christian J. CarlsonCCChristian J. Carlson
- Cristina M. RondinoneCRCristina M. Rondinone
- Bradley A. ZinkerBZBradley A. Zinker
- 30 November 2005
- journal article
- Published by Elsevier in Metabolism
- Vol. 54 (11) , 1515-1523
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Development of insulin resistance and endothelin-1 levels in the Zucker fatty ratMetabolism, 2003
- Role of Endothelin in Diabetic Vascular ComplicationsEndocrine, 2001
- PATHOPHYSIOLOGY OF ENDOTHELIN IN THE CARDIOVASCULAR SYSTEMAnnual Review of Physiology, 1999
- Endothelin-1 infusion inhibits plasma insulin responsiveness in normal menJournal Of Hypertension, 1998
- Exogenous endothelin‐1 causes peripheral insulin resistance in healthy humansActa Physiologica Scandinavica, 1997
- Circulating endothelin-1 levels in obese patients with the metabolic syndromeExperimental and Clinical Endocrinology & Diabetes, 1997
- Circulating Endothelin-1 Levels Increase During Euglycemic, Hyperinsulinemic Clamp in Lean NIDDM MenDiabetes Care, 1995
- Production of endothelin-1 from the mesenteric arteries of streptozotocin-induced diabetic ratsLife Sciences, 1991
- Elevated plasma endothelin in patients with diabetes mellitusDiabetologia, 1990
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988